EpiVax at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
EpiVax brings 6 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on new non-animal methods for judging the immunogenicity risk of biotherapeutics, and on when animal data are still needed. Its sessions also cover whole blood tests that could replace key animal immunotoxicology studies.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
EpiVax Providence, RI | |
Immunoinformatics company offering computational and laboratory immunogenicity risk assessment for biologics, plus vaccine design. | Session Mon Oct 26 10:00am–11:00am Hot Topic: Beyond Animal Models? Pros-Cons, and Regulatory Implications of NAM-Based Strategies Talk Mon Oct 26 10:15am–10:30am Talk Mon Oct 26 10:30am–11:00am Talk Mon Oct 26 1:30pm–2:30pm Talk Mon Oct 26 3:15pm–3:30pm Talk Tue Oct 27 10:30am–11:00am |
Instantly find 20 buyers from EpiVax
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction